Mesalamine Suppository
NDC Package 31722-005-31
Package Information
Mesalamine suppositories is a medication used to treat a certain bowel disease (ulcerative colitis). This formulation utilizes a suppository delivery system. Marketed by Camber Pharmaceuticals, Inc., this product is identified by NDC 31722-005 and is authorized under FDA application ANDA213377.
Identification & Billing
- RxCUI: 248420 - mesalamine 1000 MG Rectal Suppository
- RxCUI: 248420 - mesalazine 1000 MG Rectal Suppository
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 31722 - Camber Pharmaceuticals, Inc.
- 31722-005 - Mesalamine
- 31722-005-31 - 7 PACKAGE in 1 CARTON / 6 SUPPOSITORY in 1 PACKAGE (31722-005-32)
- 31722-005 - Mesalamine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (31722-005). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 31722-005-31 identifies a specific commercial package of 7 package in 1 carton / 6 suppository in 1 package (31722-005-32) of Mesalamine, a human prescription drug labeled by Camber Pharmaceuticals, Inc.. This suppository is formulated for rectal use and contains mesalamine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Camber Pharmaceuticals, Inc. on March 19, 2020. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat a certain bowel disease (ulcerative colitis). It helps to reduce symptoms of ulcerative colitis such as diarrhea, rectal bleeding, and stomach pain. Mesalamine belongs to a class of drugs known as aminosalicylates. It works by decreasing swelling in the colon.
How is this Camber Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 31722000531. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.